Vaccine Against Escherichia Coli Infection

NCT02289794 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
194
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

GlycoVaxyn AG